U of M gets $350,000 from drug companies in 2010

The University of Minnesota and the Mayo Clinic received $650,000 from drug companies in 2010.

That's from reporter Christopher Snowbeck, who analyzed annual reports to the Minnesota Board of Pharmacy for a story in today's Pioneer Press.

Snowbeck reports that $350,000 in drug company money went to the U in 2010.  The money is used to fund research and fellowship programs.

The U of M is working to foster closer relationships with business and industry, so don't be surprised if it's a source of funding that grows in coming years.

Drug company relationships with the U and its doctors was the focus of a revamped conflict of interest policy that went into place at the U just last year.

And last week the U of M sent a note caution to one of its surgeons, Dr. David Polly, noting he had violated conflict of interest closure requirements.  Polly failed to mention payments he received from Fridley-based medical device manufacturer Medtronic in two published journal articles and on one research poster.

Before you keep reading ...

MPR News is made by Members. Gifts from individuals fuel the programs that you and your neighbors rely on. Donate today to power news, analysis, and community conversations for all.